Telomerase activity in mouse myeloid leukemic cells and in cells from normal hematopoietic systems

被引:1
作者
Rithidech, K [1 ]
Gordon, CR
Cronkite, EP
机构
[1] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA
[2] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
关键词
telomerase; mouse; leukemia; radiation; blood; bone marrow;
D O I
10.1006/bcmd.2001.0412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The telomeric repeat amplification protocol (TRAP) assay was used to measure telomerase activity in radiation-induced mouse myeloid leukemic (ML) cells and in several populations of normal cells. A detectable level of telomerase activity was found in normal hematopoietic tissues, i.e., bone marrow (BM) cells, day 9 colony-forming unit spleen (CFU-S) colonies, peripheral blood (PB) lymphocytes, and spleen. The level of telomerase activity in normal BM cells was used as a background level. Nine of the I:! cases of ML had higher levels of activity than that of the normal BM cells and therefore they were scored as ML with positive telomerase. The other three cases were considered as ML with negative telomerase because the levels of the enzyme were equivalent to that of normal BM cells. The data indicate that cellular differentiation may suppress telomerase activity in mouse ML cells. In summary, the results suggest that the CBA/Ca mouse model should be a useful animal system for future studies on the assessment of telomerase activity in both malignant and normal hematopoietic cells. (C) 2001 Academic Press.
引用
收藏
页码:496 / 504
页数:9
相关论文
共 50 条
  • [1] Telomeres and telomerase in normal and leukemic hematopoietic cells
    Engelhardt, M
    Wäsch, R
    Guo, YL
    LEUKEMIA RESEARCH, 2004, 28 (10) : 1001 - 1004
  • [2] TELOMERASE ACTIVITY IN NORMAL AND MALIGNANT HEMATOPOIETIC-CELLS
    BROCCOLI, D
    YOUNG, JW
    DELANGE, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9082 - 9086
  • [3] Effect of antisense hTERT mRNA oligodeoxynucleotide on telomerase activity of leukemic cells
    Zhang, Y
    He, DM
    CELL BIOLOGY INTERNATIONAL, 2002, 26 (05) : 427 - 431
  • [4] Telomerase activity in human hematopoietic progenitor cells
    Hohaus, S
    Voso, MT
    OrtuLaBarbera, E
    Cavallo, S
    Bellacosa, A
    Rutella, S
    Rumi, C
    Genuardi, M
    Neri, G
    Leone, G
    HAEMATOLOGICA, 1997, 82 (03) : 262 - 268
  • [5] Concise review: Telomere biology in normal and leukemic hematopoietic stem cells
    Drummond, Mark W.
    Balabanov, Stefan
    Holyoake, Tessa L.
    Brummendorf, Tim H.
    STEM CELLS, 2007, 25 (08) : 1853 - 1861
  • [6] Hox regulation of normal and leukemic hematopoietic stem cells
    Abramovich, Carolina
    Humphries, R. Keith
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (03) : 210 - 216
  • [7] Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase
    Nowak, Tomasz
    Januszkiewicz, Danuta
    Zawada, Mariola
    Pernak, Monika
    Lewandowski, Krzysztof
    Rembowska, Jolanta
    Nowicka, Karina
    Mankowski, Przemyslaw
    Nowak, Jerzy
    ONCOLOGY REPORTS, 2006, 16 (02) : 301 - 305
  • [8] Lack of correlation between telomere length and telomerase activity and expression in leukemic cells
    Januszkiewicz, D
    Wysoki, J
    Lewandowski, K
    Pernak, M
    Nowicka, K
    Rembowska, J
    Nowak, J
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (06) : 935 - 938
  • [9] Leukemic cells with increased telomerase activity exhibit resistance to imatinib
    Yamada, Osamu
    Kawauchi, Kiyotaka
    Akiyama, Masaharu
    Ozaki, Kohji
    Motoji, Toshiko
    Adachi, Tomoko
    Aikawa, Eizo
    LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1168 - 1177
  • [10] Role of menin in the regulation of telomerase activity in normal and cancer cells
    Hashimoto, Manabu
    Kyo, Satoru
    Hua, Xianxin
    Tahara, Hidetoshi
    Nakajima, Miki
    Takakura, Masahiro
    Sakaguchi, Junko
    Maida, Yoshiko
    Nakamura, Mitsuhiro
    Ikoma, Tomomi
    Mizumoto, Yasunari
    Inoue, Masaki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (02) : 333 - 340